TP53 and colorectal cancer: Genomic data from more than 20,000 patients have confirmed that the TP53 is the most commonly mutated gene in all human cancers (42–44), such as hepatocellular carcinoma (45), colorectal cancer (46), lymphoma (47), and mucosal melanoma (48).